Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Cookson (London, United Kingdom). Significance of the microbiome in obstructive lung disease: where to from here?. Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation

Member's Comments

No comment yet.

Related content which might interest you: Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Gut microbiomes in chronic obstructive pulmonary disease Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Mucosal cryobiopsies: A novel method for studying obstructive airways disease? Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Chronic obstructive pulmonary disease: the patient perspective Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001 The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Chronic obstructive pulmonary disease (COPD) in children: is it possible? Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015 Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Should COPD stand for “comorbidity-related obstructive pulmonary disease”? Source: Eur Respir J 2015; 46: 901-902 Year: 2015